Circulating Tumor Cells as a Potential Biomarker in Selecting Patients for Pulmonary Metastasectomy from Colorectal Cancer:Report of a Case

Publisher： Karger

E-ISSN： 1662-6575|5|3|542-545

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.5, Iss.3, 2012-10, pp. : 542-545

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Circulating Tumor Cells and Cardiac Metastasis from Esophageal Cancer: A Case Report

By  

Case Reports in Oncology, Vol. 4, Iss. 2, 2011-05 ,pp. : 299-303

Karger

Access to resources Recommend Favorite

Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS‐BRAF wild‐type colorectal cancer receiving cetuximab or panitumumab

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 6, 2015-09 ,pp. : 1467-1474

John Wiley & Sons Inc

Access to resources Recommend Favorite

Thymidylate synthase expression in circulating tumor cells: A new tool to predict 5‐fluorouracil resistance in metastatic colorectal cancer patients

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 6, 2015-09 ,pp. : 1397-1405

John Wiley & Sons Inc

Access to resources Recommend Favorite

Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer

By  

Oncology, Vol. 92, Iss. 6, 2017-04 ,pp. : 360-370

Karger

Access to resources Recommend Favorite

Clinical significance of circulating tumor cells in peripheral blood from patients with gastric cancer

By  

CANCER, Vol. 119, Iss. 22, 2013-11 ,pp. : 3984-3991

John Wiley & Sons Inc

Access to resources Recommend Favorite